Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
Interferon regulatory factor 4 (IRF4) is a master transcription factor that regulates T helper cell (Th) differentiation. It interacts with the Basic leucine zipper transcription factor, ATF-like (BATF), depletion of which in CD4+ T cells abrogates acute graft-versus-host disease (aGVHD)-induced col...
Saved in:
| Main Authors: | Jochen T. Frueh, Julia Campe, Daniele Yumi Sunaga-Franze, Nikita A. Verheyden, Sakhila Ghimire, Elisabeth Meedt, Denise Haslinger, Sabine Harenkamp, Daniel Staudenraus, Sascha Sauer, Andreas Kreft, Ralf Schubert, Michael Lohoff, Andreas Krueger, Halvard Bonig, Andreas G. Chiocchetti, Robert Zeiser, Ernst Holler, Evelyn Ullrich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2296712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Microbiome, Inflammation, and GVHD Axis: The Balance Between the “Gut” and the Bad
by: Paula Pinzon-Leal, et al.
Published: (2025-03-01) -
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
by: Itai Falicovich, et al.
Published: (2025-01-01) -
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
by: Aviran Aharon, et al.
Published: (2025-04-01) -
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
by: Ke Zeng, et al.
Published: (2024-12-01) -
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study
by: Stefania Bramanti, et al.
Published: (2025-03-01)